AI Infrastructure Stocks Surge: MXL Rockets 29%, CNC Jumps 28% on EPS Estimate Boosts
Chip and storage stocks led Thursday's rally as AI infrastructure demand drove analyst estimate revisions. MaxLinear surged 29.1% after raising its outlook on optical data center strength, while Seagate climbed 23.9% on raised long-term guidance. Healthcare names also outperformed, with Centene jumping 27.5% following a double-upgrade on Medicaid margin recovery bets.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| MXL | Technology | 2026-04-24 | +3.7pp | +29.1% |
| CNC | Healthcare | 2026-04-24 | +0.9pp | +27.5% |
| AXSM | Healthcare | 2026-04-29 | +84.6pp | +24.2% |
| STX | Technology | 2026-04-27 | +1.7pp | +23.9% |
| KOPN | Technology | 2026-04-24 | +0.7pp | +22.7% |
Why did MXL stock jump in May 2026?
MaxLinear jumped 29.1% (from $60.32 to $77.89) after analysts raised its forward EPS growth estimate from 32.1% to 35.8% on April 24.
The chipmaker reported Q1 revenue of $137.2 million, up 43% year-over-year, with its optical data center business surging 136% as AI infrastructure demand accelerated. Needham and Roth Capital both raised ratings following the company's raised 2026 outlook, citing strong execution in AI-linked products. The stock is part of a broader semiconductor rally fueled by hyperscaler capex growth.
View screener snapshot from 2026-04-24 →
FAQ: MXL
Why did MaxLinear stock surge in April 2026?
MaxLinear stock surged 29.1% after reporting Q1 revenue of $137.2 million (up 43% YoY) and raising its 2026 outlook, with its optical data center segment growing 136% year-over-year on AI infrastructure demand.
Is MaxLinear a buy after the rally?
Needham and Roth Capital both raised ratings following the Q1 beat, with the optical data center business expected to reach $150–$170 million in 2026 revenue, suggesting further upside potential.
What caused MXL stock to jump?
MXL jumped after the company posted first-quarter results exceeding Wall Street forecasts, with its AI-linked optical data center segment driving a 136% year-over-year increase and analysts raising forward EPS estimates.
Why did CNC stock jump in May 2026?
Centene climbed 27.5% (from $41.82 to $53.33) after BofA double-upgraded the stock to Buy and raised its forward EPS growth estimate from 33.4% to 34.2% on April 24.
The managed care giant reported Q1 adjusted EPS of $3.37 and raised its full-year 2026 outlook to greater than $3.40 from greater than $3.00. BofA sees Medicaid margins bottoming in 2026 and estimates normalized earnings power around $12 per share, compared to its 2026 estimate of $3.40. The stock was also included in BofA's broader healthcare upgrade alongside Elevance Health.
View screener snapshot from 2026-04-24 →
FAQ: CNC
Why did Centene stock jump in late April 2026?
Centene stock jumped 27.5% after BofA double-upgraded it to Buy from Underperform and raised the price target from $34 to $60, citing confidence that Medicaid margins are bottoming and set for a multi-year recovery.
Is Centene a buy after the rally?
BofA estimates normalized earnings power of around $12 per share versus its 2026 estimate of $3.40, representing only 30% of target margin capacity, suggesting substantial upside if margins recover as expected.
What caused CNC stock to surge?
CNC surged after the company reported Q1 adjusted EPS of $3.37, raised its 2026 outlook above $3.40, and BofA upgraded it on expectations that Medicaid margin pressure is nearing an end.
Why did AXSM stock jump in May 2026?
Axsome Therapeutics surged 24.2% (from $183.95 to $228.49) after the FDA approved Auvelity for Alzheimer's disease agitation and analysts raised its forward EPS growth estimate from 755.6% to 840.3% on April 29.
The company reported Q1 revenue of $191.2 million, up 57% year-over-year, driven by Auvelity and Sunosi growth. Management raised Auvelity's peak sales guidance to at least $8 billion, split equally between major depressive disorder and the newly approved Alzheimer's indication, with a 630-representative sales force targeting 68,000 healthcare providers. The company added a Phase 3-ready PDE10A inhibitor (AXS-20) for schizophrenia to its pipeline.
View screener snapshot from 2026-04-29 →
FAQ: AXSM
Why did Axsome stock jump in May 2026?
Axsome stock jumped 24.2% after the FDA approved Auvelity for Alzheimer's disease agitation and the company raised peak sales guidance to $8 billion, driving a massive upward revision in forward EPS estimates.
Is Axsome a buy after the FDA approval?
With Auvelity expanding into a multi-indication franchise, a 630-representative sales force, and $305 million in cash, the company appears well-positioned for commercial execution into the newly approved Alzheimer's market.
What caused AXSM stock to surge?
AXSM surged after FDA approval of Auvelity for Alzheimer's disease agitation, Q1 revenue of $191.2 million (up 57% YoY), and raised peak sales guidance to $8 billion, prompting analysts to raise forward EPS estimates by 84.6 percentage points.
Why did STX stock jump in May 2026?
Seagate Technology rallied 23.9% (from $595.86 to $738.11) after posting strong Q1 results and raising its forward EPS growth estimate from 56.5% to 58.2% on April 27.
The data storage company raised its long-term revenue growth outlook to at least 20% annually from its prior low to mid-teens guidance, citing sustained demand from cloud customers for its tenth consecutive quarter. Seagate said nearline storage supply is nearly fully allocated through 2027, with top cloud providers holding roughly $1.1 trillion in remaining performance obligations. The stock rose alongside Western Digital and Sandisk as Meta and Microsoft raised AI capex forecasts.
View screener snapshot from 2026-04-27 →
FAQ: STX
Why did Seagate stock surge in late April 2026?
Seagate stock surged 23.9% after the company posted strong Q1 results and raised its long-term revenue growth guidance to at least 20% annually, with nearline storage supply nearly fully allocated through 2027.
Is Seagate a buy after the rally?
With top cloud providers holding $1.1 trillion in remaining performance obligations and supply nearly fully allocated through 2027, Seagate appears well-positioned to benefit from sustained AI infrastructure spending.
What caused STX stock to jump?
STX jumped after raising long-term growth guidance to 20%+ annually, driven by sustained demand from hyperscalers building AI infrastructure, with its tenth consecutive quarter of cloud customer growth.
Why did KOPN stock jump in May 2026?
Kopin gained 22.7% (from $3.70 to $4.54) after analysts raised its forward EPS growth estimate from 81.1% to 81.8% on April 24, despite no major news catalysts during the period.
The small-cap technology company operates in micro-display and semiconductor components for defense, industrial, and consumer applications. The modest 0.7 percentage point EPS revision reflects incrementally improving sentiment around the company's product pipeline and margin trajectory. The stock benefited from broader technology sector momentum, particularly among semiconductor names during the detection window.
View screener snapshot from 2026-04-24 →
FAQ: KOPN
Why did Kopin stock jump in April 2026?
Kopin stock gained 22.7% after analysts raised its forward EPS growth estimate from 81.1% to 81.8% on April 24, benefiting from broader semiconductor sector momentum despite no company-specific news.
Is Kopin a buy after the rally?
The small-cap tech company has seen incrementally positive estimate revisions, though investors should monitor its upcoming Q1 earnings call scheduled for May 12 for further operational clarity.
What caused KOPN stock to surge?
KOPN surged alongside broader semiconductor strength, with analysts raising forward EPS estimates by 0.7 percentage points as sector-wide AI infrastructure spending lifted sentiment on small-cap tech names.
AI infrastructure spending dominated Thursday's action, with semiconductor and data storage names benefiting as Meta and Microsoft raised capex forecasts. The EPS estimate revisions signal growing analyst confidence in sustained demand for optical components, storage, and chip makers tied to hyperscaler buildouts, while healthcare names like Centene and Axsome show the market is also rewarding companies with clear margin recovery or franchise expansion catalysts.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →